Cart
sales@molnova.com
(R)-(-)-Rolipram
CAS No. 85416-75-7
(R)-(-)-Rolipram( R)-Rolipram | (-)-Rolipram )
Catalog No. M16203 CAS No. 85416-75-7
A more active enantiomer of the PDE4 inhibitor rolipram.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 327 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R)-(-)-Rolipram
-
NoteResearch use only, not for human use.
-
Brief DescriptionA more active enantiomer of the PDE4 inhibitor rolipram.
-
DescriptionA more active enantiomer of the PDE4 inhibitor rolipram; shows 2-10-fold more potent than the S-(+) enantiomer rolipram.Asthma Phase 2 Clinical.
-
In VitroThe increase of cAMP synthesis with the adenylate cyclase activator forskolin or the decrease of cAMP hydrolysis by the phosphodiesterase inhibitors Isobutylmethylxanthine (IBMX) and (R)-(-)-Rolipram suppresses caspase-1 cleavage and IL-1β secretion in a dose-dependent manner.
-
In Vivo——
-
SynonymsR)-Rolipram | (-)-Rolipram
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number85416-75-7
-
Formula Weight275.3428
-
Molecular FormulaC16H21NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 49 mg/mL
-
SMILESCOC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3
-
Chemical Name2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, (4R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schneider HH, et al. Eur J Pharmacol. 1986 Aug 7;127(1-2):105-15.
2. Owens RJ, et al. Biochem J. 1997 Aug 15;326 ( Pt 1):53-60.
3. Ohsawa F, et al. Jpn J Pharmacol. 1998 Jun;77(2):147-54.
molnova catalog
related products
-
BI 1015550
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
-
Luteolin
Luteolin is a falconoid compound, which exhibits anticancer properties.
